Skip to main content
FUTURA MEDICAL PLC logo

FUTURA MEDICAL PLC — Investor Relations & Filings

Ticker · FUM ISIN · GB0033278473 LEI · 21380053QLT46UNV2303 IL Manufacturing
Open in API
Filings indexed 571 across all filing types
Latest filing 2024-09-02 Regulatory Filings
Country GB United Kingdom
Listing IL FUM

About FUTURA MEDICAL PLC

https://www.futuramedical.com/

Futura Medical is a pharmaceutical company specializing in the research, development, and global commercialization of innovative sexual health products. The company's core strength is its expertise in proprietary, topically delivered gel formulations. Its lead product, Eroxon®, is a clinically proven, fast-acting topical gel for the treatment of erectile dysfunction (ED). Eroxon® is distinguished by its rapid onset of action, helping users achieve an erection within 10 minutes, and is available over-the-counter in major markets including the USA and Europe. The company utilizes a de-risked commercialization strategy, establishing partnerships with leading consumer healthcare companies for distribution and marketing. Futura Medical's development pipeline also includes potential treatments for female sexual dysfunction.

Recent filings

Filing Released Lang Actions
Update on US Launch
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number' and contains information about an amendment to a previous announcement released via RNS. It details an update on the US launch of a product ('Eroxon's availability online and in stores') and includes contact information and standard disclaimers related to RNS distribution by the London Stock Exchange. The presence of the RNS Number, the reference to RNS distribution, and the nature of the content (a brief operational update/amendment) strongly indicate this is a general regulatory announcement. Since it is not a full financial report (10-K, IR), a specific management change (MANG), or a dividend notice (DIV), the most appropriate classification is the general regulatory filing category, RNS.
2024-09-02 English
Update on US launch
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 3888C' and contains boilerplate language referencing 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. This strongly indicates a regulatory announcement disseminated via the RNS system. The content itself is a brief update regarding the US launch availability of a product (Eroxon) by Futura Medical plc. Given its short length (under 5,000 characters) and its nature as a general operational update distributed through the official regulatory news service, it fits best under the general Regulatory Filings category (RNS), as it is not a specific financial report (like 10-K, IR, ER) or a specific corporate action announcement (like DIV, CAP, DIRS).
2024-09-02 English
Notice of Results
Report Publication Announcement Classification · 1% confidence The document is a short announcement (4203 characters) released via RNS (a regulatory news service) stating that the company, Futura Medical plc, "will announce its unaudited results for the six months ended 30 June 2024 on Tuesday 10 September 2024." It also details subsequent investor and analyst webinars. According to Rule 2, when a document is short and announces the future publication of a report (in this case, the Interim/Quarterly Report), it should be classified as a Report Publication Announcement (RPA). It is not the actual results document (which would be IR) but the notice about when the results will be released.
2024-08-19 English
Update on US launch
Regulatory Filings Classification · 1% confidence The document starts with 'RNS Number : 6717Y' and contains standard boilerplate language from RNS (the news service of the London Stock Exchange), including the disclaimer at the end: 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates a regulatory news service announcement. The content itself is a brief update on a partnership/product launch ('Update on US launch') and trading expectations, which is typical for a general regulatory announcement that doesn't fit into more specific categories like 10-K, ER, or DIV. Given its nature as a general, timely update distributed via the official regulatory feed, the most appropriate classification is Regulatory Filings (RNS). The document length is short (3804 chars), but it is providing substantive news rather than just announcing another report, making RNS more suitable than RPA.
2024-08-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is clearly identified as an 'RNS Number' announcement from the London Stock Exchange's news service. The content announces the 'Total Voting Rights' of Futura Medical PLC, stating the total issued share capital and the resulting total number of voting rights (301,863,641). This type of mandatory disclosure regarding share capital changes or total voting rights, distributed via RNS, fits best under the general 'Regulatory Filings' category, as there is no specific code for 'Total Voting Rights' announcements, and it is not a specific financial report (like 10-K or IR) or a director's dealing (DIRS). Given the source (RNS) and the nature of the announcement (a mandatory regulatory update not covered by other specific codes), RNS is the most appropriate classification.
2024-07-01 English
Nominated Adviser and Joint Broker
Board/Management Information Classification · 1% confidence The document starts with 'RNS Number : 4821U' and mentions that the information is provided by RNS, which is approved by the Financial Conduct Authority (FCA) to act as a Primary Information Provider. The content itself is a short announcement regarding a change in the company's Nominated Adviser and Joint Broker following a merger. Given its brevity (3474 characters) and its nature as a formal, non-financial-result-specific regulatory update distributed via the RNS system, it fits best under the general 'Regulatory Filings' category, as it doesn't specifically match definitions like DIRS, DIV, or CAP, and it is not an announcement of a major report (RPA).
2024-07-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.